Takeda Pharmaceuticals USA, Inc. data breach

Clerk's notes

Takeda Pharmaceuticals USA, Inc. has publicly filed a data incident notification with regulators in New Hampshire, indicating that personal information may have been exposed. This report, submitted on May 29, 2026, initiates a review process for what is currently an unspecified breach type, with the investigation status listed as ongoing.

Details regarding the specific nature of this security event and the exact categories of information involved have not been publicly disclosed. Individuals who receive a notification from Takeda Pharmaceuticals USA, Inc. should treat it seriously, as it signifies that their data may have been part of this compromise.

Those impacted by this incident are strongly encouraged to carefully read any official communication from Takeda Pharmaceuticals USA, Inc. for specific guidance provided directly by the company. This letter will contain the most direct and accurate information available to you regarding the circumstances surrounding your data.

General protective measures often include monitoring your existing accounts for any suspicious activity and considering placing a fraud alert with credit bureaus. Additionally, remain cautious about unsolicited emails, phone calls, or texts, as bad actors may attempt to use compromised information for phishing or other fraudulent schemes.

If you have received a data breach notification from Takeda Pharmaceuticals USA, Inc., understanding your rights and options is important. You may be entitled to a no-cost case review to determine if your situation warrants further action and how to protect yourself going forward.

If a notification letter about this breach reached you, see every NH data breach on file or browse all cases.